Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Quest advances SL-052 for prostate cancer in preclinical testing

May 7, 2007

Expression Genetics receives grant for development of EGEN-001 in ovarian cancer

May 7, 2007

Sapacitabine studied in new phase II trial for advanced CTCL

May 7, 2007

CyDex licenses Captisol enabling technology to Proteolix

May 7, 2007

Potent antitumor and antiangiogenic activity of LP-261 alone or in combination with bevacizumab

May 7, 2007

Preclinical findings on the anti-DR5 agonist antibody LBY-135 reported by Novartis

May 7, 2007

New preclinical data on GSK-923295 reported by GSK and Cytokinetics

May 7, 2007

Preclinical activity of the novel Aurora kinase inhibitor AZD-1152 profiled at the AACR meeting

May 7, 2007

Enzon cleared to begin phase I study of PEG-SN38 in cancer

May 4, 2007

Belinostat studied with doxorubicin in new phase I/II trial for soft tissue sarcomas

May 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...